OrbiMed’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.7M | Buy |
|
|||||
2025
Q1 | $31.3M | Buy |
|
|||||
2024
Q4 | – | Sell |
|
|||||
2024
Q3 | $36.6M | Sell |
|
|||||
2024
Q2 | $50M | Buy |
|
|||||
2024
Q1 | $76.3M | Buy |
|
|||||
2023
Q4 | $55.2M | Sell |
|
|||||
2023
Q3 | $47.9M | Buy |
|
|||||
2023
Q2 | $82.9M | Hold |
|
|||||
2023
Q1 | $60M | Buy |
|
|||||
2020
Q2 | – | Sell |
|
|||||
2020
Q1 | $1.35M | Buy |
|
|||||
2019
Q4 | – | Sell |
|
|||||
2019
Q3 | $15M | Sell |
|
|||||
2019
Q2 | $46.2M | Buy |
|
|||||
2019
Q1 | $34.4M | Buy |
|
|||||
2018
Q4 | $4.31M | Buy |
|